An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma

Abstract

Tumor-associated autoimmune reactions may be triggered by early stage HCCs. Measurement of serum autoantibody to TAAs may be complementary to AFP measurements and improve diagnosis of early HCC.